Singapore markets closed

Straits Times Index
3,307.90
-6.15(-0.19%)
S&P 500
5,313.10
+4.97(+0.09%)
Dow
39,867.34
+60.57(+0.15%)
Nasdaq
16,791.15
-3.72(-0.02%)
Bitcoin USD
70,761.65
+3,993.72(+5.98%)
CMC Crypto 200
1,532.39
+43.85(+2.94%)

BMY Jan 2025 30.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

14.23

0.00

(0.00%)

As of 12:35PM EDT. Market open.

Business Wire
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
Business Wire
Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivo and hyaluronidase)
Simply Wall St.
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...